{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:14:46Z","timestamp":1777018486379,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/ki.2012.460","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T13:54:16Z","timestamp":1358344456000},"page":"915-923","source":"Crossref","is-referenced-by-count":28,"title":["Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Thomas","family":"Idorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip K","family":"Knop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Hornum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2012.460_bb0010","first-page":"175","article-title":"Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance","volume":"31","author":"Alvestrand","year":"1989","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2012.460_bb0015","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1172\/JCI107624","article-title":"Hyperglucagonemia of renal failure","volume":"53","author":"Bilbrey","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2012.460_bb0020","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0026-0495(78)80005-5","article-title":"Pathogenesis of glucose intolerance in uremia","volume":"27","author":"DeFronzo","year":"1978","journal-title":"Metabolism"},{"key":"10.1038\/ki.2012.460_bb0025","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ndt\/gfp558","article-title":"Pre-diabetes and arterial stiffness in uraemic patients","volume":"25","author":"Hornum","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2012.460_bb0030","doi-asserted-by":"publisher","first-page":"c47","DOI":"10.1159\/000112529","article-title":"Evidence for increased risk of prediabetes in the uremic patient","volume":"108","author":"Eldin","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2012.460_bb0035","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01225454","article-title":"The incretin concept today","volume":"16","author":"Creutzfeldt","year":"1979","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0040","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/BF00281990","article-title":"New developments in the incretin concept","volume":"28","author":"Creutzfeldt","year":"1985","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0045","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0050","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1210\/jc.2010-2435","article-title":"Impaired regulation of the incretin effect in patients with type 2 diabetes","volume":"96","author":"Bagger","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0055","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0060","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0065","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2337\/db07-0100","article-title":"Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?","volume":"56","author":"Knop","year":"2007","journal-title":"Diabetes"},{"key":"10.1038\/ki.2012.460_bb0070","doi-asserted-by":"publisher","first-page":"E832","DOI":"10.1152\/ajpendo.00700.2009","article-title":"Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes","volume":"298","author":"Hare","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1038\/ki.2012.460_bb0075","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.2337\/dc11-s227","article-title":"Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes","volume":"34","author":"Holst","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2012.460_bb0080","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1210\/jc.2010-0119","article-title":"Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects","volume":"95","author":"Hansen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0085","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.regpep.2010.05.011","article-title":"Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis","volume":"164","author":"Knop","year":"2010","journal-title":"Regul Pept"},{"key":"10.1038\/ki.2012.460_bb0090","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJM197108192850806","article-title":"Glucagon physiology and pathophysiology","volume":"285","author":"Unger","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.460_bb0095","first-page":"E283","article-title":"Impact of lack of suppression of glucagon on glucose tolerance in humans","volume":"277","author":"Shah","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2012.460_bb0100","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/BF00281991","article-title":"Glucagon physiology and pathophysiology in the light of new advances","volume":"28","author":"Unger","year":"1985","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0105","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2012.460_bb0110","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1038\/ki.2012.460_bb0115","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2012.460_bb0120","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2012.460_bb0125","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/MNH.0b013e32834b23c1","article-title":"Measurement of insulin resistance in chronic kidney disease","volume":"20","author":"Pham","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2012.460_bb0130","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/0026-0495(82)90158-5","article-title":"Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients","volume":"31","author":"Lauritzen","year":"1982","journal-title":"Metabolism"},{"key":"10.1038\/ki.2012.460_bb0135","doi-asserted-by":"publisher","first-page":"E1144","DOI":"10.1152\/ajpendo.00571.2005","article-title":"Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance","volume":"291","author":"Muscelli","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0140","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0026-0495(77)90086-5","article-title":"Renal effects on serum gastric inhibitory polypeptide (GIP)","volume":"26","author":"O'Dorisio","year":"1977","journal-title":"Metabolism"},{"key":"10.1038\/ki.2012.460_bb0145","first-page":"769","article-title":"Gastrointestinal hormone profile in renal insufficiency","volume":"54","author":"Owyang","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/ki.2012.460_bb0150","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"10.1038\/ki.2012.460_bb0155","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/s-2007-1002190","article-title":"Renal catabolism of truncated glucagon-like peptide 1","volume":"25","author":"Ruiz-Grande","year":"1993","journal-title":"Horm Metab Res"},{"key":"10.1038\/ki.2012.460_bb0160","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.metabol.2005.03.024","article-title":"Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus","volume":"54","author":"Henkel","year":"2005","journal-title":"Metabolism"},{"key":"10.1038\/ki.2012.460_bb0165","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJM197007162830301","article-title":"Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion","volume":"283","author":"Muller","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.460_bb0170","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/jcem-64-1-106","article-title":"Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus","volume":"64","author":"Reaven","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0175","first-page":"379","article-title":"All products of proglucagon are elevated in plasma from uremic patients","volume":"74","author":"Orskov","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0180","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1172\/JCI108330","article-title":"Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon","volume":"57","author":"Sherwin","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2012.460_bb0185","doi-asserted-by":"publisher","first-page":"E1038","DOI":"10.1152\/ajpendo.00665.2010","article-title":"The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes","volume":"300","author":"Lund","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.2010.03791.x","article-title":"Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage","volume":"73","author":"Klose","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1038\/ki.2012.460_bb0195","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1210\/jc.2011-0266","article-title":"Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans","volume":"96","author":"Lindgren","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.460_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc. Ser B"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815558225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815558225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T19:42:26Z","timestamp":1714851746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815558225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0085253815558225"],"URL":"https:\/\/doi.org\/10.1038\/ki.2012.460","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}